Secondary sites of the C-type lectin-like fold.

Lectins Structural Biology protein fold secondary sites

Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
25 Mar 2024
Historique:
revised: 23 03 2024
received: 18 02 2024
accepted: 25 03 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

C-type lectins are a large superfamily of proteins involved in a multitude of biological processes. In particular, their involvement in immunity and homeostasis has rendered them attractive targets for diverse therapeutic interventions. They share a characteristic C-type lectin-like domain whose adaptability enables them to bind a broad spectrum of ligands beyond the originally defined canonical Ca2+-dependent carbohydrate binding. Together with variable domain architecture and high-level conformational plasticity, this enables C-type lectins to meet diverse functional demands. Secondary sites provide another layer of regulation and are often intricately linked to functional diversity. Located remote from the canonical primary binding site, secondary sites can accommodate ligands with other physicochemical properties and alter protein dynamics, thus enhancing selectivity and enabling fine-tuning of the biological response. In this review, we outline the structural determinants allowing C-type lectins to perform a large variety of tasks and to accommodate the ligands associated with it. Using the six well-characterized Ca2+-dependent and Ca2+-independent C-type lectin receptors DC-SIGN, langerin, MGL, dectin-1, CLEC-2 and NKG2D as examples, we focus on the characteristics of non-canonical interactions and secondary sites and their potential use in drug discovery endeavors.

Identifiants

pubmed: 38527187
doi: 10.1002/chem.202400660
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400660

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Jonathan Lefebre (J)

University of Vienna, Department of Pharmaceutical Sciences, AUSTRIA.

Torben Falk (T)

University of Vienna, Department of Pharmaceutical Sciences, AUSTRIA.

Yunzhan Ning (Y)

University of Vienna, Department of Pharmaceutical Sciences, AUSTRIA.

Christoph Rademacher (C)

University of Vienna, Department of Pharmaceutical Sciences, 1090, Wien, AUSTRIA.

Classifications MeSH